Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "operations"

932 News Found

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform
Biotech | May 12, 2022

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform

The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams


FirstCure Health raises US $350 K in the Pre-Seed funding round
Startup | May 11, 2022

FirstCure Health raises US $350 K in the Pre-Seed funding round

The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations


Bayer posts higher sales, profit in first quarter
News | May 11, 2022

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1


Premas Biotech appoints Saumen Chakraborty to its Board
People | May 09, 2022

Premas Biotech appoints Saumen Chakraborty to its Board

Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad


Avantor to create a new manufacturing hub in Singapore
News | May 05, 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year


StanPlus appoints Gurjit Singh as COO and Founding Member
People | May 02, 2022

StanPlus appoints Gurjit Singh as COO and Founding Member

He will be leading the business, operations, P&L, and growth strategy for StanPlus


USFDA concludes inspection of Shilpa Medicare with four observations
News | May 02, 2022

USFDA concludes inspection of Shilpa Medicare with four observations

The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory


Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
News | April 29, 2022

Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar

The plant is expected to start commercial operations from Q4FY24


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo


Beta Drugs announces oultook for FY 22-23
News | April 28, 2022

Beta Drugs announces oultook for FY 22-23

The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years